Sertraline Hydrochloride

Product NDC
70954-899
11-digit product format
709540899
Labeler code
70954
Product ID
70954-899_dfc9fee6-c032-4994-9f14-5beaf39bb5d5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sertraline Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
ANI Pharmaceuticals, Inc.
Application
ANDA219714
Marketing category
ANDA
Marketing start
2026-01-20
Substance
SERTRALINE HYDROCHLORIDE
Active strength
150 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219714-001SERTRALINE HYDROCHLORIDESERTRALINE HYDROCHLORIDEEQ 150MG BASECAPSULE / ORALAB2026-01-20
A219714-002SERTRALINE HYDROCHLORIDESERTRALINE HYDROCHLORIDEEQ 200MG BASECAPSULE / ORALAB2026-01-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A219714-001AB
A219714-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A219714-001SERTRALINE HYDROCHLORIDEEQ 150MG BASECAPSULE / ORALAB2026-01-2084e616aacf4f…
2026-09-14 22:38:342026-08A219714-002SERTRALINE HYDROCHLORIDEEQ 200MG BASECAPSULE / ORALAB2026-01-2084e616aacf4f…
2026-08-18 06:07:402026-07A219714-001SERTRALINE HYDROCHLORIDEEQ 150MG BASECAPSULE / ORALAB2026-01-20caaa826d4ba7…
2026-08-18 06:07:402026-07A219714-002SERTRALINE HYDROCHLORIDEEQ 200MG BASECAPSULE / ORALAB2026-01-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219714-001SERTRALINE HYDROCHLORIDEEQ 150MG BASECAPSULE / ORALAB2026-01-20011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219714-002SERTRALINE HYDROCHLORIDEEQ 200MG BASECAPSULE / ORALAB2026-01-20011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219714-001SERTRALINE HYDROCHLORIDEEQ 150MG BASECAPSULE / ORALAB2026-01-20a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219714-002SERTRALINE HYDROCHLORIDEEQ 200MG BASECAPSULE / ORALAB2026-01-20a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A219714-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A219714-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A219714-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A219714-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219714-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219714-002AB1011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219714-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219714-002AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Sertraline Hydrochloride
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SERTRALINE HYDROCHLORIDE150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
UTI8907Y6XInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
251201Internal RxNorm lookup
410584Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
dfc9fee6-c032-4994-9f14-5beaf39bb5d5Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4ac594ea-ad8b-47fd-9b52-bbd98301675eProduct name120220317
255fa467-900b-5557-4215-6823352d1150Product name220211028

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70954-899-10Sertraline Hydrochloride30 in 1 BOTTLECAPSULE301

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70954-899-10EA - Each70954-8990c1ba754-6319-473f-95ee-815e8b54215212026-02-05

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sertraline HydrochlorideSERTRALINE HYDROCHLORIDEANI Pharmaceuticals, Inc.dfc9fee6-c032-4994-9f14-5beaf39bb5d52024-07-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219714
application number: ANDA219714
ndc (product): 70954-899

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
410584sertraline 150 MG Oral CapsulePSNdfc9fee6-c032-4994-9f14-5beaf39bb5d51
410584sertraline 150 MG Oral CapsuleSCDdfc9fee6-c032-4994-9f14-5beaf39bb5d51
251201sertraline 200 MG Oral CapsuleSCDdfc9fee6-c032-4994-9f14-5beaf39bb5d51
410584sertraline 150 MG (as sertraline HCl 168 MG) Oral CapsuleSYdfc9fee6-c032-4994-9f14-5beaf39bb5d51
251201sertraline 200 MG (as sertraline HCl 224 MG) Oral CapsuleSYdfc9fee6-c032-4994-9f14-5beaf39bb5d51

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70954-899-107095408991030 CAPSULE in 1 BOTTLE (70954-899-10) 30 capsule2026-01-20NoNoCurrent